Sort
85,873 grants matching “alzheimers”
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimer's Disease
$853,475Yadong Huang · J. David Gladstone Institutes · R01 · FY2020 · AG
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
$853,313Gunvant K Thaker · University Of Maryland Baltimore · R01 · FY2007 · MH
Characterizing the Function of miRNAs in Neural Development, Synaptic Plasticity and Schizophrenia.
$853,209Zheng Li · National Institute Of Mental Health · ZIA · FY2015 · MH
Preventing Tau uptake by novel inhibitors of tau binding to LRP1
$853,145Kenneth S Kosik · University Of California Santa Barbara · R01 · FY2023 · AG
Endothelial complement C3a receptor mediated cerebral injury in a murine stroke model.
$853,135Andrew Frederick Ducruet · St. Joseph'S Hospital And Medical Center · R01 · FY2024 · NS
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
$853,100Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2020 · AG
Role of age, dopamine, and tau related network disruption in setting a context for progression toward Alzheimer's Disease
$852,984Julius C Hedden · Massachusetts General Hospital · R01 · FY2018 · AG
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
$852,908Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AG
Blood mitochondrial DNA biomarkers of midlife cognitive decline and adverse brain imaging changes - A longitudinal investigation in the CARDIA populationâbased cohort study
$852,784Andrea Baccarelli · Columbia University Health Sciences · R01 · FY2020 · AG
Clinical Core
$852,575Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2020 · AG
CAREER: Leaving the Fold: Leveraging Mass Spectrometry Proteomics to Shift the Paradigm on Protein Folding
$852,387Stephen D Fried · Johns Hopkins University · · FY2021 · BIO
Role of EphA1/A2 domain-domain and -membrane interactions for receptor specificity and Blood Brain Barrier dysfunction
$852,309Matthias Buck · Case Western Reserve University · R01 · FY2024 · AG
Genetic Mapping of m6A and Pseudouridine RNA Modifications in the Aging Human Brain and Their Impact on Alzheimer's Disease
$852,273Gao Wang · Columbia University Health Sciences · R01 · FY2025 · AG
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
$852,235Robert W. Mahley · J. David Gladstone Institutes · U01 · FY2012 · AG
Creating adaptive, wearable technologies to assess and intervene for individuals with ADRDs
$852,202Diane Joyce Cook · Washington State University · R35 · FY2024 · AG
A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD)
$852,049Liron Danay Sinvani · Feinstein Institute For Medical Research · R01 · FY2025 · AG
Cell models for AD:Lipids and related signaling pathways
$852,032University Of Missouri-Columbia · P01 · FY2001 · AG
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$851,900Sung Ok Yoon · Ohio State University · R01 · FY2017 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$851,784Kurt R. Brunden · University Of Pennsylvania · U01 · FY2021 · AG
Characterization of AD-related endolysosomal dysfunction in human neural cells
$851,663Jessica Elaine Young · University Of Washington · R01 · FY2024 · AG
A Portable PET Insert System for Simultaneous TOF-PET and MR Brain Imaging
$851,630Chenming Chang · Petcoil, Inc. · R44 · FY2024 · MH
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
$851,505Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus
$851,427Peter J Fried · Beth Israel Deaconess Medical Center · R01 · FY2024 · AG
Determining the role of OXR1 in aging and Alzheimer's disease
$851,414Pankaj Kapahi · Buck Institute For Research On Aging · R56 · FY2021 · AG
Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus
$851,245Peter J Fried · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG